Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined electroconvulsive-clozapine therapy.

M Kupchik1, B Spivak, R Mester

  • 1Ness Ziona Mental Health Center, Israel.

Clinical Neuropharmacology
|February 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study.

Schizophrenia research·2020
Same author

The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.

European psychiatry : the journal of the Association of European Psychiatrists·2018
Same author

The Effectiveness of a Knowledge Translation Cognitive-Educational Intervention for Family Members of Persons Coping with Severe Mental Illness.

Community mental health journal·2017
Same author

CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice.

Journal of molecular neuroscience : MN·2016
Same author

Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease.

Cell death discovery·2016
Same author

The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood-brain barrier permeability.

Journal of affective disorders·2016
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Combining electroconvulsive therapy (ECT) with clozapine offers a safe and effective treatment option for psychiatric patients resistant to other therapies. This combined approach showed significant patient benefit and manageable side effects.

Area of Science:

  • Psychiatry
  • Neuroscience

Background:

  • Treatment resistance is a significant challenge in managing psychiatric disorders.
  • Conventional antipsychotics, clozapine, and electroconvulsive therapy (ECT) alone may not be sufficient for some patients.

Purpose of the Study:

  • To evaluate the efficacy and safety of combined electroconvulsive therapy (ECT) and clozapine treatment.
  • To assess this combination as a therapeutic option for treatment-resistant psychiatric patients.

Main Methods:

  • A review of 36 psychiatric patients who received combined ECT and clozapine therapy.
  • Analysis of patient response and adverse events associated with the combined treatment.

Main Results:

  • Sixty-seven percent of patients demonstrated benefit from the combined ECT-clozapine treatment.

Related Experiment Videos

  • The combined treatment was generally safe and well-tolerated.
  • Adverse reactions (16.6%) included prolonged seizures, tachycardia, and blood pressure elevation.

    • Conclusions:

    • Combined ECT and clozapine treatment appears to be an effective strategy for treatment-resistant psychiatric conditions.
    • This therapeutic combination presents a viable option for patients who have not responded to other treatments.